{
    "data": [
        {
            "title": "CERT-In warns Apple users of critical flaws in outdated software versions",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><div>\r\n\tThe Indian Computer Emergency Response Team (CERT-In) has issued an advisory for Apple users, warning of security vulnerabilities in devices running older software versions. The advisory applies to iPhones with iOS versions earlier than the recently released <a href=\"https://www.business-standard.com/technology/tech-news/apple-releases-ios-18-3-update-for-iphones-what-is-new-and-how-to-download-125012800254_1.html\" target=\"_blank\">iOS 18.3</a>, as well as outdated iPads, Apple Watches, Macs, and versions of Apple's Safari web browser.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tCERT-In has categorised these vulnerabilities as \"High risk,\" cautioning that they could allow attackers to gain unauthorised access to sensitive data, disrupt services, or manipulate information. The advisory noted that both individual users and organisations could be impacted.</div>\n<div>\n<div>\n<strong class=\"read_more\">ALSO READ: <a href=\"https://www.business-standard.com/technology/tech-news/cert-in-issues-urgent-security-alert-over-vulnerabilities-in-google-chrome-125012700309_1.html\" target=\"_blank\">CERT-In issues urgent security alert over vulnerabilities in Google Chrome</a></strong></div></div><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_2-0\" style=\"min-height:250px\"></div>\n<div>\r\n\tAmong the reported security flaws, CERT-In highlighted CVE-2025-24085 as a critical issue that has been \"exploited in the wild.\" This vulnerability is identified as a \"use-after-free bug\" in the Core Media component, occurring due to improper handling of dynamic memory. If exploited, it could enable malicious apps to gain elevated privileges on affected devices.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tApple has addressed these security flaws in its latest software updates for iPhones, iPads, Apple Watches, and Macs. CERT-In advises users to update their devices to the latest versions to mitigate risks and safeguard against potential threats.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tThe full list of affected software includes:</div><div id=\"between_article_content_3-0\" style=\"min-height:250px\"></div>\n<ul>\n<li>\r\n\t\tiOS versions before 18.3</li>\n<li>\r\n\t\tiPadOS versions before 18.3</li>\n<li>\r\n\t\tiPadOS versions before 17.7.4</li>\n<li>\r\n\t\tApple macOS Sequoia versions before 15.3</li>\n<li>\r\n\t\tApple macOS Sonoma versions before 14.7.3</li>\n<li>\r\n\t\tApple macOS Ventura versions before 13.7.3</li>\n<li>\r\n\t\tApple watchOS versions before 11.3</li>\n<li>\r\n\t\tApple visionOS versions before 2.3</li>\n<li>\r\n\t\tApple Safari versions before 18.3</li>\n<li>\r\n\t\tApple tvOS versions before 18.3</li>\n</ul></div>",
            "pub_date": "2025-02-04 14:10:29",
            "link": "https://www.business-standard.com/technology/tech-news/cert-in-warns-apple-users-of-critical-flaws-in-outdated-software-versions-125020400409_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400409"
        },
        {
            "title": "OYO to invest Rs 539.57 crore in UK to expand premium hotel portfolio",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><p>\r\n\tTravel tech unicorn OYO on Tuesday said it plans to invest 50 million pounds (Rs 539.57 crore) in the UK over the next three years, primarily to focus on expanding its premium hotel portfolio.</p>\n<p>\r\n\tThe investment is expected to support 1,000 jobs over the next three years in the UK hospitality sector, OYO said in a statement.</p>\n<p>\r\n\tIn a significant strategic shift, OYO is actively pursuing premiumization of its UK portfolio, by pivoting towards premium inventory acquisition, focusing on securing long-term leasehold and management contracts.</p>\n<p>\r\n\tThe company is also in advanced stage talks with several large hotel chains and real estate companies for potential asset management transactions.</p><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_2-0\" style=\"min-height:250px\"></div>\n<p>\r\n\t\"OYO's investment in premium hotels will not only strengthen our tourism infrastructure, but back our ambitious 'Showcase Britain' initiative, helping to boost economic growth as part of our Plan for Change,\" said the UK Minister for Investment Baroness Poppy Gustafsson OBE in the statement.</p><div class=\"mb-20\"><div class=\"latestnews_stryalsoread__HlMna\"></div></div>\n<p>\r\n\tPuneet Yadav, Country Head - OYO UK said, OYO entered the UK market in 2018, leveraging a model that had proven successful in other global markets.</p>\n<p>\r\n\t\"While we continue to cater to the budget segment, we are now focused on expanding through leasehold agreements and management contracts with premium properties. Additionally, we plan to introduce several of our popular European brands to the UK market, further diversifying our offerings and meeting evolving customer needs,\" Yadav stated.</p><div id=\"between_article_content_3-0\" style=\"min-height:250px\"></div>\n<p>\r\n\tThe investment was announced on the sidelines of the Nasscom delegation to the UK organized by The Department of Business and Trade, UK.</p>\n<p>\r\n\tAppreciating the role being played by tech startups in strengthening the Indo UK trade, Rajesh Nambiar, President Nasscom said, \"India's tech startup ecosystem has evolved into a global force, driving innovation and economic growth beyond its borders. Proud to see tech startups like OYO strengthening trade ties between both the nations, playing a crucial role in increasing the bilateral trade from $42 billion to $50 billion and beyond\".</p>\n<p>\r\n\tOYO has over 200 hotels mostly in the budget segment spread across 65 cities in the UK with London, Manchester, Birmingham, Cardiff and Brighton, being the main clusters.</p><div id=\"between_article_content_4-0\" style=\"min-height:250px\"></div>\n<p>\r\n\tThe company recently announced its plans to open over 40 premium self-operated hotels through leasehold contracts in this financial year.</p>\n<p>\r\n\tIt has already on-boarded 18 hotels under this model and plans to add 22 more across key cities including London, Birmingham, Manchester, Liverpool, Glasgow, Bristol, Cardiff, and Edinburgh.</p>\n<p>\r\n\tIn 2024, OYO's parent company, Oravel Stays Limited, marked its entry into the UK's premium segment with the launch of SUNDAY Lansbury Heritage in Canary Wharf.</p><p></p></div>",
            "pub_date": "2025-02-04 14:10:28",
            "link": "https://www.business-standard.com/companies/news/oyo-to-invest-rs-539-57-crore-in-uk-to-expand-premium-hotel-portfolio-125020400261_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400261"
        },
        {
            "title": "CERT-In warns Apple users of critical flaws in outdated software versions",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><div>\r\n\tThe Indian Computer Emergency Response Team (CERT-In) has issued an advisory for Apple users, warning of security vulnerabilities in devices running older software versions. The advisory applies to iPhones with iOS versions earlier than the recently released <a href=\"https://www.business-standard.com/technology/tech-news/apple-releases-ios-18-3-update-for-iphones-what-is-new-and-how-to-download-125012800254_1.html\" target=\"_blank\">iOS 18.3</a>, as well as outdated iPads, Apple Watches, Macs, and versions of Apple's Safari web browser.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tCERT-In has categorised these vulnerabilities as \"High risk,\" cautioning that they could allow attackers to gain unauthorised access to sensitive data, disrupt services, or manipulate information. The advisory noted that both individual users and organisations could be impacted.</div>\n<div>\n<div>\n<strong class=\"read_more\">ALSO READ: <a href=\"https://www.business-standard.com/technology/tech-news/cert-in-issues-urgent-security-alert-over-vulnerabilities-in-google-chrome-125012700309_1.html\" target=\"_blank\">CERT-In issues urgent security alert over vulnerabilities in Google Chrome</a></strong></div></div><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_2-0\" style=\"min-height:250px\"></div>\n<div>\r\n\tAmong the reported security flaws, CERT-In highlighted CVE-2025-24085 as a critical issue that has been \"exploited in the wild.\" This vulnerability is identified as a \"use-after-free bug\" in the Core Media component, occurring due to improper handling of dynamic memory. If exploited, it could enable malicious apps to gain elevated privileges on affected devices.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tApple has addressed these security flaws in its latest software updates for iPhones, iPads, Apple Watches, and Macs. CERT-In advises users to update their devices to the latest versions to mitigate risks and safeguard against potential threats.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tThe full list of affected software includes:</div><div id=\"between_article_content_3-0\" style=\"min-height:250px\"></div>\n<ul>\n<li>\r\n\t\tiOS versions before 18.3</li>\n<li>\r\n\t\tiPadOS versions before 18.3</li>\n<li>\r\n\t\tiPadOS versions before 17.7.4</li>\n<li>\r\n\t\tApple macOS Sequoia versions before 15.3</li>\n<li>\r\n\t\tApple macOS Sonoma versions before 14.7.3</li>\n<li>\r\n\t\tApple macOS Ventura versions before 13.7.3</li>\n<li>\r\n\t\tApple watchOS versions before 11.3</li>\n<li>\r\n\t\tApple visionOS versions before 2.3</li>\n<li>\r\n\t\tApple Safari versions before 18.3</li>\n<li>\r\n\t\tApple tvOS versions before 18.3</li>\n</ul></div>",
            "pub_date": "2025-02-04 14:05:27",
            "link": "https://www.business-standard.com/technology/tech-news/cert-in-warns-apple-users-of-critical-flaws-in-outdated-software-versions-125020400409_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400409"
        },
        {
            "title": "OYO to invest Rs 539.57 crore in UK to expand premium hotel portfolio",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><p>\r\n\tTravel tech unicorn OYO on Tuesday said it plans to invest 50 million pounds (Rs 539.57 crore) in the UK over the next three years, primarily to focus on expanding its premium hotel portfolio.</p>\n<p>\r\n\tThe investment is expected to support 1,000 jobs over the next three years in the UK hospitality sector, OYO said in a statement.</p>\n<p>\r\n\tIn a significant strategic shift, OYO is actively pursuing premiumization of its UK portfolio, by pivoting towards premium inventory acquisition, focusing on securing long-term leasehold and management contracts.</p>\n<p>\r\n\tThe company is also in advanced stage talks with several large hotel chains and real estate companies for potential asset management transactions.</p><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_2-0\" style=\"min-height:250px\"></div>\n<p>\r\n\t\"OYO's investment in premium hotels will not only strengthen our tourism infrastructure, but back our ambitious 'Showcase Britain' initiative, helping to boost economic growth as part of our Plan for Change,\" said the UK Minister for Investment Baroness Poppy Gustafsson OBE in the statement.</p><div class=\"mb-20\"><div class=\"latestnews_stryalsoread__HlMna\"></div></div>\n<p>\r\n\tPuneet Yadav, Country Head - OYO UK said, OYO entered the UK market in 2018, leveraging a model that had proven successful in other global markets.</p>\n<p>\r\n\t\"While we continue to cater to the budget segment, we are now focused on expanding through leasehold agreements and management contracts with premium properties. Additionally, we plan to introduce several of our popular European brands to the UK market, further diversifying our offerings and meeting evolving customer needs,\" Yadav stated.</p><div id=\"between_article_content_3-0\" style=\"min-height:250px\"></div>\n<p>\r\n\tThe investment was announced on the sidelines of the Nasscom delegation to the UK organized by The Department of Business and Trade, UK.</p>\n<p>\r\n\tAppreciating the role being played by tech startups in strengthening the Indo UK trade, Rajesh Nambiar, President Nasscom said, \"India's tech startup ecosystem has evolved into a global force, driving innovation and economic growth beyond its borders. Proud to see tech startups like OYO strengthening trade ties between both the nations, playing a crucial role in increasing the bilateral trade from $42 billion to $50 billion and beyond\".</p>\n<p>\r\n\tOYO has over 200 hotels mostly in the budget segment spread across 65 cities in the UK with London, Manchester, Birmingham, Cardiff and Brighton, being the main clusters.</p><div id=\"between_article_content_4-0\" style=\"min-height:250px\"></div>\n<p>\r\n\tThe company recently announced its plans to open over 40 premium self-operated hotels through leasehold contracts in this financial year.</p>\n<p>\r\n\tIt has already on-boarded 18 hotels under this model and plans to add 22 more across key cities including London, Birmingham, Manchester, Liverpool, Glasgow, Bristol, Cardiff, and Edinburgh.</p>\n<p>\r\n\tIn 2024, OYO's parent company, Oravel Stays Limited, marked its entry into the UK's premium segment with the launch of SUNDAY Lansbury Heritage in Canary Wharf.</p><p></p></div>",
            "pub_date": "2025-02-04 14:05:27",
            "link": "https://www.business-standard.com/companies/news/oyo-to-invest-rs-539-57-crore-in-uk-to-expand-premium-hotel-portfolio-125020400261_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400261"
        },
        {
            "title": "CERT-In warns Apple users of critical flaws in outdated software versions",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><div>\r\n\tThe Indian Computer Emergency Response Team (CERT-In) has issued an advisory for Apple users, warning of security vulnerabilities in devices running older software versions. The advisory applies to iPhones with iOS versions earlier than the recently released <a href=\"https://www.business-standard.com/technology/tech-news/apple-releases-ios-18-3-update-for-iphones-what-is-new-and-how-to-download-125012800254_1.html\" target=\"_blank\">iOS 18.3</a>, as well as outdated iPads, Apple Watches, Macs, and versions of Apple's Safari web browser.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tCERT-In has categorised these vulnerabilities as \"High risk,\" cautioning that they could allow attackers to gain unauthorised access to sensitive data, disrupt services, or manipulate information. The advisory noted that both individual users and organisations could be impacted.</div>\n<div>\n<div>\n<strong class=\"read_more\">ALSO READ: <a href=\"https://www.business-standard.com/technology/tech-news/cert-in-issues-urgent-security-alert-over-vulnerabilities-in-google-chrome-125012700309_1.html\" target=\"_blank\">CERT-In issues urgent security alert over vulnerabilities in Google Chrome</a></strong></div></div><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_2-0\" style=\"min-height:250px\"></div>\n<div>\r\n\tAmong the reported security flaws, CERT-In highlighted CVE-2025-24085 as a critical issue that has been \"exploited in the wild.\" This vulnerability is identified as a \"use-after-free bug\" in the Core Media component, occurring due to improper handling of dynamic memory. If exploited, it could enable malicious apps to gain elevated privileges on affected devices.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tApple has addressed these security flaws in its latest software updates for iPhones, iPads, Apple Watches, and Macs. CERT-In advises users to update their devices to the latest versions to mitigate risks and safeguard against potential threats.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tThe full list of affected software includes:</div><div id=\"between_article_content_3-0\" style=\"min-height:250px\"></div>\n<ul>\n<li>\r\n\t\tiOS versions before 18.3</li>\n<li>\r\n\t\tiPadOS versions before 18.3</li>\n<li>\r\n\t\tiPadOS versions before 17.7.4</li>\n<li>\r\n\t\tApple macOS Sequoia versions before 15.3</li>\n<li>\r\n\t\tApple macOS Sonoma versions before 14.7.3</li>\n<li>\r\n\t\tApple macOS Ventura versions before 13.7.3</li>\n<li>\r\n\t\tApple watchOS versions before 11.3</li>\n<li>\r\n\t\tApple visionOS versions before 2.3</li>\n<li>\r\n\t\tApple Safari versions before 18.3</li>\n<li>\r\n\t\tApple tvOS versions before 18.3</li>\n</ul></div>",
            "pub_date": "2025-02-04 14:00:34",
            "link": "https://www.business-standard.com/technology/tech-news/cert-in-warns-apple-users-of-critical-flaws-in-outdated-software-versions-125020400409_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400409"
        },
        {
            "title": "DLF, Lodha: 5 real-estate shares that can gain upto 16% ahead of RBI Policy",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div>The NSE Nifty Realty index was up 0.8 per cent at 958 in intra-day deals on Tuesday amid a positive market trend. In comparison, the benchmarks, the Nifty 50 had gained 0.5 per cent at 23,480, and the BSE Sensex was up 0.5 per cent or 400 points at 77,600 levels.<small class=\"brtagPara\"> </small> In the run-up the Union Budget, and now upcoming RBI Policy on February 07, (Friday), the Nifty Realty index has rallied in the last seven straight trading sessions, up 14 per cent during this period. Technically, the Nifty Realty index has been seeking support on the long-term chart at its 20-MMA (Monthly Moving Average) - a key indicator the index has held since May 2023. The 20-MMA at present stands at 888.<small class=\"brtagPara\"> </small> The buying frenzy in real-estate stocks can be attributed to a <a href=\"https://www.business-standard.com/markets/news/union-budget-2025-26-consumption-over-capex-rise-of-the-middle-class-125020300114_1.html?1738646572\" target=\"_blank\"><strong>pro-middle class Budget 2025</strong></a>, wherein the finance minister has exempted tax on income up to Rs 12 lakh from financial year 2025-26 onwards. That apart, the Street is now expecting a 25 basis points rate cut in the <a href=\"https://www.business-standard.com/finance/news/bs-poll-rbi-expected-to-reduce-policy-repo-rate-by-25-basis-points-125020200562_1.html?1738646572\" target=\"_blank\"><strong>upcoming RBI Policy</strong></a>.<small class=\"brtagPara\"> </small> As such, can real-estate stocks extend the current rally or will they hit a roadblock going ahead? Here's how the key realty stocks are placed on the technical charts.<small class=\"brtagPara\"> </small> <strong>Nifty Realty</strong><small class=\"brtag\"> </small> Current Level: 958<small class=\"brtag\"> </small> Upside Potential: 13.4%<small class=\"brtag\"> </small> Support: 915; 890<small class=\"brtag\"> </small> Resistance: 1,010<small class=\"brtagPara\"> </small> The Nifty Realty index has logged gains for the last seven straight trading sessions. In the process, the index is seen quoting above its 20-DMA (Daily Moving Average) for the last three trading sessions, and has also given a buy signal on the super trend line. <a href=\"https://bsmedia.business-standard.com/_media/bs/data/general-file-upload/2025-02/NIFTYREALTY_040225.jpg\" target=\"_blank\"><strong>CLICK HERE FOR THE CHART</strong></a><small class=\"brtagPara\"> </small> Thus, the near-term bias for the Nifty Realty index is expected to remain favourable as long as the index holds above 890 levels; with near support for the index seen around its 20-DMA at 915 levels. On the upside, the Nifty Realty can rally towards 1,086; with interim resistance expected around 1,010 levels. Do note the broader trend of the Realty index looks weak, as the index has been making lower highs and lower lows on the weekly scale.<small class=\"brtagPara\"> </small> <strong>ALSO READ: <a href=\"https://www.business-standard.com/markets/news/nifty-realty-stocks-trade-below-200-dmas-index-down-18-in-jan-what-next-125012300483_1.html?1738646648\" target=\"_blank\">Nifty Realty stocks trade below 200-DMAs; index down 18% in Jan; what next?</a></strong><small class=\"brtagPara\"> </small> <strong>DLF</strong><small class=\"brtag\"> </small> Current Price: Rs 762<small class=\"brtag\"> </small> Upside Potential: 15.9%<small class=\"brtag\"> </small> Support: Rs 738; Rs 700<small class=\"brtag\"> </small> Resistance: Rs 810; Rs 838<small class=\"brtagPara\"> </small> DLF stock has gained nearly 11 per cent from its recent low of Rs 691. The stock at present is seen within striking distance of its near-term hurdle at Rs 783; above which the stock can potentially rally to Rs 883. Interim resistance for the stock can be anticipated around Rs 810 and Rs 838 levels. On the downside, the stock has near support at Rs 738, below which the key long-term support stands at Rs 700. <a href=\"https://bsmedia.business-standard.com/_media/bs/data/general-file-upload/2025-02/DLF_040225.jpg\" target=\"_blank\"><strong>CLICK HERE FOR THE CHART</strong></a><small class=\"brtagPara\"> </small> <strong>Godrej Properties</strong><small class=\"brtag\"> </small> Current Price: Rs 2,400<small class=\"brtag\"> </small> Upside Potential: 12.5%<small class=\"brtag\"> </small> Support: Rs 2,305; Rs 2,233<small class=\"brtag\"> </small> Resistance: Rs 2,500; Rs 2,627<small class=\"brtagPara\"> </small> Godrej Properties is seen attempting a positive breakout on the daily scale; a close above Rs 2,390 will confirm the same. On the upside, the stock can potentially spurt towards Rs 2,700 levels; with intermediate resistance expected around Rs 2,500 and Rs 2,627 levels. Key supports on the downside stand at Rs 2,305 and Rs 2,233. <a href=\"https://bsmedia.business-standard.com/_media/bs/data/general-file-upload/2025-02/GODREJPROP_040225.jpg\" target=\"_blank\"><strong>CLICK HERE FOR THE CHART</strong></a><small class=\"brtagPara\"> </small> <strong>ALSO READ: <a href=\"https://www.business-standard.com/markets/news/nifty-may-target-24-300-post-budget-trump-tariff-rbi-policy-key-triggers-125020101053_1.html?1738646648\" target=\"_blank\">Nifty may target 24,300 post Budget; Trump tariff, RBI policy key triggers</a></strong><small class=\"brtagPara\"> </small> <strong>Macrotech Developers (Lodha)</strong><small class=\"brtag\"> </small> Current Price: Rs 1,278<small class=\"brtag\"> </small> Upside Potential: 13.5%<small class=\"brtag\"> </small> Support: Rs 1,180<small class=\"brtag\"> </small> Resistance: Rs 1,300; Rs 1,370<small class=\"brtagPara\"> </small> Shares of Lodha have rallied by 24 per cent from the January lows of Rs 1,053. The stock is now seen testing resistance around the key hurdle at Rs 1,300. Break and sustained trade above the same can trigger a rally towards Rs 1,450; with interim resistance likely around Rs 1,370. On the downside, the stock can slip back to Rs 1,180 in case of profit-taking. <a href=\"https://bsmedia.business-standard.com/_media/bs/data/general-file-upload/2025-02/LODHA_040225.jpg\" target=\"_blank\"><strong>CLICK HERE FOR THE CHART</strong></a><small class=\"brtagPara\"> </small> <strong>Oberoi Realty</strong><small class=\"brtag\"> </small> Current Price: Rs 1,816<small class=\"brtag\"> </small> Upside Potential: 12.9%<small class=\"brtag\"> </small> Support: Rs 1,773; Rs 1,707<small class=\"brtag\"> </small> Resistance: Rs 1,930<small class=\"brtagPara\"> </small> Oberoi Realty has climbed back above its 200-DMA, which stands at Rs 1,773. The near-term bias is likely to remain cautiously optimistic as long as the stock trades above Rs 1,773 and Rs 1,707 support area. On the upside, the stock needs to break and trade consistently above Rs 1,930 for further gains up to Rs 2,050. <a href=\"https://bsmedia.business-standard.com/_media/bs/data/general-file-upload/2025-02/OBEROIRLTY_040225.jpg\" target=\"_blank\"><strong>CLICK HERE FOR THE CHART</strong></a><small class=\"brtagPara\"> </small> <strong>Phoenix Mills</strong><small class=\"brtag\"> </small> Current Price: Rs 1,770<small class=\"brtag\"> </small> Upside Potential: 14.4%<small class=\"brtag\"> </small> Support: Rs 1,722; Rs 1,670; Rs 1,650<small class=\"brtag\"> </small> Resistance: Rs 1,865; Rs 1,900<small class=\"brtagPara\"> </small> Phoenix Mills has soared by 27.5 per cent from its low of Rs 1,450 on January 27 to a high of Rs 1,850 yesterday. In the process, the stock managed to cross all the key moving averages on the daily scale. For now, the stock is expected to trade with a positive bias as long as the stock holds above the 100-DMA at Rs 1,650. Near support for the stock exists at 1,722 and Rs 1,670. On the upside, the stock seems on course to test Rs 2,025 levels; with interim resistance placed at Rs 1,865 and Rs 1,900 levels. <a href=\"https://bsmedia.business-standard.com/_media/bs/data/general-file-upload/2025-02/PHOENIX_040225.jpg\" target=\"_blank\"><strong>CLICK HERE FOR THE CHART</strong></a><small class=\"brtagPara\"> </small><br/></div>",
            "pub_date": "2025-02-04 14:00:33",
            "link": "https://www.business-standard.com/markets/news/dlf-lodha-5-real-estate-shares-that-can-gain-upto-16-ahead-of-rbi-policy-125020400410_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400410"
        },
        {
            "title": "Gland Pharma shares slip 5% on disappointing revenue growth in Q3",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><div>\r\n\tShares of Gland Pharma slipped 5 per cent to Rs 1,437.70 on the BSE in Tuesday’s intra-day trade after the company’s revenues de-grew 10 per cent year-on-year (YoY) to Rs 1,384 crore in the December quarter (Q3FY25). The company's topline was impacted by the low base business arising due to a dip in volumes in the US as well as some shipment delays to Saudi Arabia.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tIn comparison, the BSE Sensex was up 0.3 per cent at 77,417, at 10:40 AM. The stock price of Gland Pharma had hit a 52-week low of Rs 1,413.75 on January 28, 2025. It has corrected 35 per cent from its 52-week high level of Rs 2,220.95 touched on August 6, 2024.</div><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_2-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tThe company' reported earnings before interest, tax, depreciation and amortisation (Ebitda), on the other hand, grew 1 per cent YoY to Rs 360 crore, and margins stood at 26 per cent (300 bps growth) driven by a strong 535 bps improvement in gross profit margin. Profit after tax grew 7 per cent YoY to Rs 204.7 crore.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tIn the base business, the US de-grew 12 per cent YoY to Rs 713.5 crore due to a postponement of supplies of blood thinner, Enoxaparin to the next quarter. Rest of world (RoW) reported 6 per cent YoY growth to Rs 167 crore, while the domestic business de-grew 26 per cent YoY to Rs 56 crore. The Cenexi business remained impacted due to machinery breakdown in a Belgium plant and to address observations emanating from an unannounced inspection by the French regulator.</div><div id=\"between_article_content_3-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tOn a negative note, the company's management now expects the Cenexi turnaround to happen in Q3FY26F (vs. Q4FY25F earlier), given the Lyophilizer breakdown at the Belgium plant and the observations received for the Fontenay, Belgium, plant from the French health authorities at the recent inspection.</div><div class=\"mb-20\"><div class=\"latestnews_stryalsoread__HlMna\"></div></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tICICI Securities said Gland’s base business revenues were negatively impacted by the postponement of Enoxaparin revenues to the next quarter but this had positive implications on the margins as Enoxaparin fetches lower margins. The Cenexi business was also impacted by unforeseen events, however the postponement of positive margins (Ebitda) to Q3FY26 is a matter of slight concern. </div><div id=\"between_article_content_4-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tThat said, the brokerage firm expects normalcy to return in a quarter or two. The future holds good for Gland with the expected approvals for complex products , GLP 1 contract signing and an agreement with a Chinese biotech player for biosimilars besides incremental Cenexi revenues from the new high-speed line from Fontenay plant. The new CEO has been assigned to take charge of RoW and India businesses, ICICI Securities said in a note.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tAnalysts at InCred Equities said they are disappointed with the repeated delay in Cenexi’s turnaround and will reassess the situation constructively once the facility is back on track. It has been nearly seven quarters since Cenexi’s acquisition, and it will take another three-to-four quarters for the business to normalise, they said. </div><div id=\"between_article_content_5-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tWhile Gland’s core business continues to outperform, Cenexi’s ongoing challenges will remain a drag in the near-term. As a result, the brokerage firm has reduced its FY25F/26F EPS estimates by 14 per cent/24 per cent, respectively, and lowered the target price to Rs 1,313, from Rs 1,768 earlier. A faster-than-expected ramp-up at Cenexi remains a key upside risk, the brokerage firm said in the company's results update.</div>\n<small class=\"brtagPara\"> </small> <small class=\"brtagPara\"> </small></div>",
            "pub_date": "2025-02-04 13:55:27",
            "link": "https://www.business-standard.com/markets/news/gland-pharma-slips-5-on-disappointing-revenue-growth-in-q3-125020400323_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400323"
        },
        {
            "title": "CERT-In warns Apple users of critical flaws in outdated software versions",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><div>\r\n\tThe Indian Computer Emergency Response Team (CERT-In) has issued an advisory for Apple users, warning of security vulnerabilities in devices running older software versions. The advisory applies to iPhones with iOS versions earlier than the recently released <a href=\"https://www.business-standard.com/technology/tech-news/apple-releases-ios-18-3-update-for-iphones-what-is-new-and-how-to-download-125012800254_1.html\" target=\"_blank\">iOS 18.3</a>, as well as outdated iPads, Apple Watches, Macs, and versions of Apple's Safari web browser.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tCERT-In has categorised these vulnerabilities as \"High risk,\" cautioning that they could allow attackers to gain unauthorised access to sensitive data, disrupt services, or manipulate information. The advisory noted that both individual users and organisations could be impacted.</div>\n<div>\n<div>\n<strong class=\"read_more\">ALSO READ: <a href=\"https://www.business-standard.com/technology/tech-news/cert-in-issues-urgent-security-alert-over-vulnerabilities-in-google-chrome-125012700309_1.html\" target=\"_blank\">CERT-In issues urgent security alert over vulnerabilities in Google Chrome</a></strong></div></div><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_2-0\" style=\"min-height:250px\"></div>\n<div>\r\n\tAmong the reported security flaws, CERT-In highlighted CVE-2025-24085 as a critical issue that has been \"exploited in the wild.\" This vulnerability is identified as a \"use-after-free bug\" in the Core Media component, occurring due to improper handling of dynamic memory. If exploited, it could enable malicious apps to gain elevated privileges on affected devices.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tApple has addressed these security flaws in its latest software updates for iPhones, iPads, Apple Watches, and Macs. CERT-In advises users to update their devices to the latest versions to mitigate risks and safeguard against potential threats.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tThe full list of affected software includes:</div><div id=\"between_article_content_3-0\" style=\"min-height:250px\"></div>\n<ul>\n<li>\r\n\t\tiOS versions before 18.3</li>\n<li>\r\n\t\tiPadOS versions before 18.3</li>\n<li>\r\n\t\tiPadOS versions before 17.7.4</li>\n<li>\r\n\t\tApple macOS Sequoia versions before 15.3</li>\n<li>\r\n\t\tApple macOS Sonoma versions before 14.7.3</li>\n<li>\r\n\t\tApple macOS Ventura versions before 13.7.3</li>\n<li>\r\n\t\tApple watchOS versions before 11.3</li>\n<li>\r\n\t\tApple visionOS versions before 2.3</li>\n<li>\r\n\t\tApple Safari versions before 18.3</li>\n<li>\r\n\t\tApple tvOS versions before 18.3</li>\n</ul></div>",
            "pub_date": "2025-02-04 13:55:26",
            "link": "https://www.business-standard.com/technology/tech-news/cert-in-warns-apple-users-of-critical-flaws-in-outdated-software-versions-125020400409_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400409"
        },
        {
            "title": "China imposes 10-15% tax on select US goods in response to Trump tariffs",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><div>\r\n\tChina on Monday announced its decision to impose tariffs ranging from 10 to 15 per cent on select  goods from the United States starting February 10, marking a significant escalation in trade tensions between the two countries. This action is a direct response to the US government's recent decision to levy a 10 per cent tariff on Chinese products, citing concerns over China's handling of fentanyl control.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tIn addition to the tariffs, China has also introduced a set of export controls on crucial minerals and launched an anti-monopoly probe targeting US tech giant Google. This further intensifies the ongoing trade conflict, which has already strained relations between the U.S. and China.</div><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_2-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\n<div>\r\n\t\tEarlier today, President Donald Trump agreed to delay the imposition of a 25 per cent tariff on goods from Canada and Mexico for 30 days, easing the possibility of a trade war with the two neighboring countries. However, the 10 per cent tariff on Chinese imports is still expected to go into effect 00:01 EST (05:00 GMT) onwards on Tuesday.</div>\n<small class=\"brtag\"> </small></div>\n<small class=\"brtag\"> </small></div>",
            "pub_date": "2025-02-04 13:50:31",
            "link": "https://www.business-standard.com/world-news/china-tariffs-us-imports-oil-farm-products-cars-donald-trump-trade-war-125020400402_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400402"
        },
        {
            "title": "Gland Pharma shares slip 5% on disappointing revenue growth in Q3",
            "description": "<div id=\"parent_top_div\" style=\"margin:0 0\"><div id=\"between_article_content_1-0\" style=\"min-height:250px\"></div><div>\r\n\tShares of Gland Pharma slipped 5 per cent to Rs 1,437.70 on the BSE in Tuesday’s intra-day trade after the company’s revenues de-grew 10 per cent year-on-year (YoY) to Rs 1,384 crore in the December quarter (Q3FY25). The company's topline was impacted by the low base business arising due to a dip in volumes in the US as well as some shipment delays to Saudi Arabia.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tIn comparison, the BSE Sensex was up 0.3 per cent at 77,417, at 10:40 AM. The stock price of Gland Pharma had hit a 52-week low of Rs 1,413.75 on January 28, 2025. It has corrected 35 per cent from its 52-week high level of Rs 2,220.95 touched on August 6, 2024.</div><span style=\"display:block;height:1px\"> </span><div id=\"between_article_content_2-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tThe company' reported earnings before interest, tax, depreciation and amortisation (Ebitda), on the other hand, grew 1 per cent YoY to Rs 360 crore, and margins stood at 26 per cent (300 bps growth) driven by a strong 535 bps improvement in gross profit margin. Profit after tax grew 7 per cent YoY to Rs 204.7 crore.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tIn the base business, the US de-grew 12 per cent YoY to Rs 713.5 crore due to a postponement of supplies of blood thinner, Enoxaparin to the next quarter. Rest of world (RoW) reported 6 per cent YoY growth to Rs 167 crore, while the domestic business de-grew 26 per cent YoY to Rs 56 crore. The Cenexi business remained impacted due to machinery breakdown in a Belgium plant and to address observations emanating from an unannounced inspection by the French regulator.</div><div id=\"between_article_content_3-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tOn a negative note, the company's management now expects the Cenexi turnaround to happen in Q3FY26F (vs. Q4FY25F earlier), given the Lyophilizer breakdown at the Belgium plant and the observations received for the Fontenay, Belgium, plant from the French health authorities at the recent inspection.</div><div class=\"mb-20\"><div class=\"latestnews_stryalsoread__HlMna\"></div></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tICICI Securities said Gland’s base business revenues were negatively impacted by the postponement of Enoxaparin revenues to the next quarter but this had positive implications on the margins as Enoxaparin fetches lower margins. The Cenexi business was also impacted by unforeseen events, however the postponement of positive margins (Ebitda) to Q3FY26 is a matter of slight concern. </div><div id=\"between_article_content_4-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tThat said, the brokerage firm expects normalcy to return in a quarter or two. The future holds good for Gland with the expected approvals for complex products , GLP 1 contract signing and an agreement with a Chinese biotech player for biosimilars besides incremental Cenexi revenues from the new high-speed line from Fontenay plant. The new CEO has been assigned to take charge of RoW and India businesses, ICICI Securities said in a note.</div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tAnalysts at InCred Equities said they are disappointed with the repeated delay in Cenexi’s turnaround and will reassess the situation constructively once the facility is back on track. It has been nearly seven quarters since Cenexi’s acquisition, and it will take another three-to-four quarters for the business to normalise, they said. </div><div id=\"between_article_content_5-0\" style=\"min-height:250px\"></div>\n<small class=\"brtag\"> </small>\n<div>\r\n\tWhile Gland’s core business continues to outperform, Cenexi’s ongoing challenges will remain a drag in the near-term. As a result, the brokerage firm has reduced its FY25F/26F EPS estimates by 14 per cent/24 per cent, respectively, and lowered the target price to Rs 1,313, from Rs 1,768 earlier. A faster-than-expected ramp-up at Cenexi remains a key upside risk, the brokerage firm said in the company's results update.</div>\n<small class=\"brtagPara\"> </small> <small class=\"brtagPara\"> </small></div>",
            "pub_date": "2025-02-04 13:50:29",
            "link": "https://www.business-standard.com/markets/news/gland-pharma-slips-5-on-disappointing-revenue-growth-in-q3-125020400323_1.html",
            "source": "business-standard",
            "kind": 1,
            "language": "en",
            "id": "125020400323"
        }
    ]
}